Literature DB >> 33479799

Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease.

Doaa El Amrousy1, Heba El Ashry2, Sara Maher3, Salwa Ganna4, Samir Hasan5.   

Abstract

Association between pulmonary function tests (PFTs) and non-alcoholic fatty liver disease (NAFLD) has been reported in adult studies; however, there is lack of pediatric studies. Our study aimed to evaluate PFTs in children with NAFLD. A total of 137 children with NAFLD and 100 healthy children of matched age and sex were included in the study. Different PFTs including forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, residual volume (RV), and total lung capacity (TLC) were performed for all included children. Lipid profile, insulin resistance, fasting and postprandial glucose level, and high sensitive C reactive protein (hs-CRP) were measured. FEV1 %, FVC %, FEV1/FVC ratio, RV, and TLC were significantly lower in the patient group compared with the control group (P < 0.05), while RV and hs-CRP were significantly higher in children with NAFLD. Restrictive lung dysfunction was the commonest pulmonary dysfunction detected in children with NAFLD (21.9%). PFT indices were significantly correlated with grade and duration of NAFLD, insulin resistance, waist circumference, and hs-CRP. Regression analysis revealed that insulin resistance and hs-CRP were independently associated with decreased PFT indices.
Conclusion: PFT indices were impaired in children with NAFLD and this impairment was independently associated with insulin resistance and hs-CRP. What is Known: • Pulmonary function tests (PFTs) abnormalities are common in adults with nonalcoholic fatty liver disease (NAFLD). • Studies involving PFTs abnormalities in pediatric NAFLD are lacking. What is New: • It is the first study that assessed PFT in pediatric patients with NAFLD. • PFTs abnormalities are present in children with NAFLD. • Insulin resistance and high sensitive C reactive protein are independently associated with the decline of PFTs in children with NAFLD.

Entities:  

Keywords:  Adolescents; Children; Insulin resistance; Non-alcoholic fatty liver disease; Pulmonary function; hs-CRP

Mesh:

Year:  2021        PMID: 33479799     DOI: 10.1007/s00431-021-03941-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  34 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.

Authors:  Ho Cheol Hong; Soon Young Hwang; Hae Yoon Choi; Hye Jin Yoo; Ji A Seo; Sin Gon Kim; Nan Hee Kim; Sei Hyun Baik; Dong Seop Choi; Kyung Mook Choi
Journal:  Hepatology       Date:  2014-03-24       Impact factor: 17.425

Review 3.  NAFLD: a multisystem disease.

Authors:  Christopher D Byrne; Giovanni Targher
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 4.  Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment.

Authors:  Anna Alisi; Stefano Cianfarani; Melania Manco; Carlo Agostoni; Valerio Nobili
Journal:  Ann Med       Date:  2011-02-28       Impact factor: 4.709

Review 5.  Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.

Authors:  Alessandro Mantovani; Christopher D Byrne; Enzo Bonora; Giovanni Targher
Journal:  Diabetes Care       Date:  2018-02       Impact factor: 19.112

6.  Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.

Authors:  Saleh Amin; Doaa El Amrousy; Shaymaa Elrifaey; Rasha Gamal; Hossam Hodeib
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-01       Impact factor: 2.839

7.  Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.

Authors:  Giovanni Targher; Christopher D Byrne; Amedeo Lonardo; Giacomo Zoppini; Corrado Barbui
Journal:  J Hepatol       Date:  2016-05-17       Impact factor: 25.083

8.  Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents.

Authors:  Debbie A Lawlor; Mark Callaway; Corrie Macdonald-Wallis; Emma Anderson; Abigail Fraser; Laura D Howe; Chris Day; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2014-01-28       Impact factor: 5.958

9.  Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.

Authors:  Maria Perticone; Antonio Cimellaro; Raffaele Maio; Benedetto Caroleo; Angela Sciacqua; Giorgio Sesti; Francesco Perticone
Journal:  Int J Mol Sci       Date:  2016-03-26       Impact factor: 5.923

10.  Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease.

Authors:  Doaa El Amrousy; Dalia El-Afify
Journal:  Cytokine       Date:  2020-07-27       Impact factor: 3.861

View more
  3 in total

1.  Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease.

Authors:  Lei Miao; Li Yang; Li-Sha Guo; Qiang-Qiang Shi; Teng-Fei Zhou; Yang Chen; Huai Zhang; Hui Cai; Zhi-Wei Xu; Shuan-Ying Yang; Hai Lin; Zhe Cheng; Ming-Yang Zhu; Xu Nan; Shuai Huang; Ya-Wen Zheng; Giovanni Targher; Christopher D Byrne; Yu-Ping Li; Ming-Hua Zheng; Cheng-Shui Chen
Journal:  J Clin Transl Hepatol       Date:  2022-01-04

2.  Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial.

Authors:  Doaa El Amrousy; Heba Elashry; Abeer Salamah; Sara Maher; Sherief M Abd-Elsalam; Samir Hasan
Journal:  J Inflamm Res       Date:  2022-03-29

3.  Greater Muscular Strength Is Associated with a Lower Risk of Pulmonary Dysfunction in Individuals with Non-Alcoholic Fatty Liver Disease.

Authors:  Jinkyung Cho; Bruce D Johnson; Kymberly D Watt; Chul-Ho Kim
Journal:  J Clin Med       Date:  2022-07-17       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.